Home
NewsNewsIVI RMA North America has launched the IVI RMA Patient Advisory Council in the US and Canada to strengthen patient-centered care. The councils bring patients, clinicians, and leadership together in structured monthly discussions, ensuring real patient experiences inform fertility care improvements, service innovation, and long-term clinical strategies.
In a decisive stride toward deeper patient engagement, IVI RMA North America has introduced two new Patient Advisory Councils, one in the United States and one in Canada, designed to elevate firsthand experiences into strategic action. These councils are set up as collaborative forums where patients, their partners, and clinical teams come together in open dialogue to shape the future of care delivery with empathy and clarity.
Launching virtually on December 16, 2025, in the U.S. and January 14, 2026, in Canada, the IVI RMA Patient Advisory Council initiative will meet monthly, building ongoing channels for real-time feedback that influence care standards and organizational priorities. Featuring a blend of patient representatives from each market alongside practice leaders, medical directors, and executive teams, these councils aim to fuse real lived experiences with system-wide planning.
According to Iris González, Chief Operating Officer at IVI RMA North America, this approach will help the organization refine its patient-centered care by listening to what truly matters to the people they serve, driving improvements grounded in authenticity rather than assumption. Leadership across the network will harness insights from these advisory bodies to steer enhancements across patient services, engagement, and innovative care programs.
IVI RMA North America, home to iconic fertility brands including Reproductive Medicine Associates, Boston IVF, and TRIO has built its reputation on evidence-based treatments and cutting-edge research, contributing to more than 220,000 births to date. With these councils in motion, the network is poised to set a new benchmark for patient partnership in reproductive health care.
Wisconsin lawmakers from both parties are proposing bills to reduce IVF treatment costs. Republicans suggest a $5,000 tax credit for expenses, while Democrats want mandatory insurance coverage. With IVF cycles costing $20,000-$30,000 and 170,000 residents facing infertility, both parties seek affordable solutions through different approaches.
The AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
Alife Health secured CE Mark approval for its AI-powered embryo selection tool, Embryo Predict, under EU MDR, expanding its fertility technology presence across Europe.
Simbryo Technologies introduces the Simbryo FX personalized assay, a diagnostic test that measures endometrial fertility to predict embryo implantation success and improve IVF outcomes with more than 90% specificity.
South Korean couples travel abroad for gender-selective IVF procedures, spending dollars in Thailand and Cyprus due to domestic legal restrictions on choosing a baby's sex.
As more families pursue fertility treatments, IVF CRYO urges greater transparency and safety in better Safe Embryos and Eggs Shipping across the U.S.
China sees a rise in advanced maternal age In Vitro Fertilization, driven by BaseCare Medical’s AI undisturbed culture system that improves embryo quality and clinical pregnancy rates, especially with PGT. Localized AI-assisted solutions position BaseCare as a leader in smart, precision reproduction technology for older IVF patients.
